PBI-4050 Improves Metabolic Regulation and Diabetic Nephropathy through Reduction of ER Stress, Pro-Inflammatory/Fibrotic Markers, Galectin-

June 22, 2018

What Does this Study Demonstrate?

This study demonstrates that PBI-4050:

  • Improves triglyceride and glucose metabolism
  • Reduces collagen and galectin-3 deposition in WAT and kidney
  • Reduces ER stress and pro-inflammatory/fibrotic markers in kidney

These results suggest that PBI-4050 is a strong potential candidate for the treatment of metabolic diseases and related diabetic nephropathy.

 

 

Previous Flipbook
PBI-4547 Improves Glucose Metabolism and Insulin Resistance, and Reduces Liver Damage in a High-Fat Diet Mouse Model of Obesity and Metaboli
PBI-4547 Improves Glucose Metabolism and Insulin Resistance, and Reduces Liver Damage in a High-Fat Diet Mouse Model of Obesity and Metaboli

Taken together, these results suggest that PBI-4547 offers the potential as a novel therapy for Non-alcohol...

Next Flipbook
PBI-4547 Reverses Diabetes and Metabolic Syndrome through Regulation of Lipid/Glucose Metabolism, -Oxidation and Fibrosis in Liver and Whit
PBI-4547 Reverses Diabetes and Metabolic Syndrome through Regulation of Lipid/Glucose Metabolism, -Oxidation and Fibrosis in Liver and Whit

PBI-4547 reduces: Blood glucose, cholesterol and triglycerides levels Pro-inflammatory and pro-fibrotic ma...